Page last updated: 2024-10-31

n(1),n(11)-diethylnorspermine and Central Nervous System Diseases

n(1),n(11)-diethylnorspermine has been researched along with Central Nervous System Diseases in 1 studies

N(1),N(11)-diethylnorspermine: structure given in first source

Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.

Research Excerpts

ExcerptRelevanceReference
"Fifteen patients with advanced solid tumors were entered into a phase I study of DENSPM given by a 1 h i."2.68Unusual central nervous system toxicity in a phase I study of N1N11 diethylnorspermine in patients with advanced malignancy. ( Berghorn, E; Creaven, PJ; Levine, E; Loewen, G; Meropol, NJ; Pendyala, L; Perez, R; Raghavan, D, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Creaven, PJ1
Perez, R1
Pendyala, L1
Meropol, NJ1
Loewen, G1
Levine, E1
Berghorn, E1
Raghavan, D1

Trials

1 trial available for n(1),n(11)-diethylnorspermine and Central Nervous System Diseases

ArticleYear
Unusual central nervous system toxicity in a phase I study of N1N11 diethylnorspermine in patients with advanced malignancy.
    Investigational new drugs, 1997, Volume: 15, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Area Under Curve; Biological Availability; Centr

1997